Clinical Trials in Australia

Active recruiting clinical trials with sites in Australia. Select a condition below to see detailed trial listings.

Total Trials: 254 // Recruiting: 254 // Updated: Daily

Australia currently has 254 clinical trials with at least one registered site in the country, of which 254 are actively recruiting participants. The most studied conditions at Australia sites are Prostate Cancer, Advanced Solid Tumor, Breast Cancer, reflecting where local investigators and sponsors are concentrating enrolment.

Studies are led by sponsors including AstraZeneca, Merck Sharp & Dohme LLC, GlaxoSmithKline. By stage, active Australia trials break down as Phase 1 (83), Phase 2 (73), Phase 3 (83), Phase 4 (4). All figures update daily from ClinicalTrials.gov — select a condition below for full listings, eligibility and site contacts.

Top Conditions in Australia

Prostate Cancer 8 Advanced Solid Tumor 7 Breast Cancer 6 Multiple Myeloma 5 Colorectal Cancer 5 Bladder Cancer 5 Melanoma 5 Solid Tumors 4 Solid Tumor, Adult 4 Advanced Solid Tumors 4 Chronic Lymphocytic Leukemia 3 Advanced Cancer 3 Obesity 3 Acute Myeloid Leukemia 3 Mantle Cell Lymphoma 3 Healthy Volunteer 3 Heart Failure 3 Lung Cancer 3 Esophageal Cancer 3 Pancreatic Cancer 3

All Countries → All Trials →

Other Countries in This Region

🇯🇵Japan 🇰🇷South Korea

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology